tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chiara Russo, 5 are a BUY (62.5%), 3 are a HOLD (37.5%).
Analyst Chiara Russo, currently employed carries an average stock price target met ratio of 75% that have a potential upside of 53.83% achieved within 281 days. Previously, Chiara Russo worked at CANTOR FITZGERALD.
Chiara Russo’s has documented 17 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BDSI, BioDelivery Sciences International at 17-May-2017.
Analyst best performing recommendations are on ASRT (ASSERTIO THERAPEUTICS).
The best stock recommendation documented was for ASRT (ASSERTIO THERAPEUTICS) at 3/19/2015. The price target of $88 was fulfilled within 7 days with a profit of $11.48 (11.54%) receiving and performance score of 16.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$2.97 (288.35%)
$4
10 months 23 days ago
(04-Jan-2024)
1/5 (20%)
$3.1 (344.44%)
184
Buy
$4
$2.97 (288.35%)
$6
1 years 24 days ago
(03-Nov-2023)
1/5 (20%)
$1.66 (70.94%)
289
Hold
$16
$14.89 (1341.44%)
$52
5 years 3 months 18 days ago
(08-Aug-2019)
1/5 (20%)
$4.76 (42.35%)
59
Hold
$12
$9.09 (312.37%)
$28
5 years 6 months 10 days ago
(16-May-2019)
9/12 (75%)
$5.34 (9.39%)
50
Buy
$40
6 years 2 months 29 days ago
(29-Aug-2018)
1/9 (11.11%)
$6.64 (19.90%)
120
What Year was the first public recommendation made by Chiara Russo?
